Literature DB >> 1735196

Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A-binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells.

T Uchiyama1, M Araake, X J Yan, Y Miyanaga, H Igarashi.   

Abstract

Human umbilical vascular endothelial cells (HUVEC) express HLA class II molecules upon stimulation with recombinant human interferon-gamma (IFN-gamma). Staphylococcal enterotoxin (SE) A (SEA)-binding assay using [125I]-SEA showed the presence of specific SEA binding in HUVEC stimulated with IFN-gamma but not in unstimulated HUVEC. Levels of HLA class II expression and SEA-binding increased as the IFN-gamma concentration and the period of stimulation were increased. Binding of [125I]-SEA to the IFN-gamma-stimulated HUVEC was reduced markedly by an anti-DR/DP MoAb. T cells produced IL-2 upon stimulation with a group of SEs (SEA, SEB, SEC, SED and SEE) in the presence HUVEC stimulated with IFN-gamma but not in the presence of control HUVEC. The level of accessory cell activity in the IFN-gamma-stimulated HUVEC was related to the level of HLA class II expression and SEA-binding activity. Antibodies to HLA class II molecules almost completely inhibited the response. These results indicate that HLA class II molecules are directly involved in the acquisition of these activities in HUVEC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735196      PMCID: PMC1554270          DOI: 10.1111/j.1365-2249.1992.tb02995.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.

Authors:  K Imanishi; H Igarashi; T Uchiyama
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

2.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.

Authors:  T Uchiyama; S Saito; H Inoko; X J Yan; K Imanishi; M Araake; H Igarashi
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

3.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.

Authors:  J A Mollick; R G Cook; R R Rich
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

4.  Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.

Authors:  T Herrmann; R S Accolla; H R MacDonald
Journal:  Eur J Immunol       Date:  1989-11       Impact factor: 5.532

5.  Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.

Authors:  T Uchiyama; Y Kamagata; X J Yan; A Kawachi; H Fujikawa; H Igarashi; M Okubo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.

Authors:  T Uchiyama; K Imanishi; S Saito; M Araake; X J Yan; H Fujikawa; H Igarashi; H Kato; F Obata; N Kashiwagi
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

7.  Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.

Authors:  P Scholl; A Diez; W Mourad; J Parsonnet; R S Geha; T Chatila
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  HLA antigen expression on cultured human arterial endothelial cells.

Authors:  B H Markus; Y L Colson; J J Fung; A Zeevi; R J Duquesnoy
Journal:  Tissue Antigens       Date:  1988-11

9.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

10.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Phenotypic modulation of cultured endothelial cells in collagen matrices induced by tumor necrosis factor alpha.

Authors:  S Nakatani; L Lu; N Okada; K Yoshikawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

3.  Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.

Authors:  K Riesbeck; A Billström; J Tordsson; T Brodin; K Kristensson; M Dohlsten
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation.

Authors:  M Kraft; S Filsinger; K L Krämer; D Kabelitz; G M Hänsch; M Schoels
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  Regulation of staphylococcal enterotoxin B-elicited nitric oxide production by endothelial cells.

Authors:  R D LeClaire; W M Kell; R A Sadik; M B Downs; G W Parker
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

Review 6.  Staphylococcus aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments.

Authors:  Nour Ahmad-Mansour; Paul Loubet; Cassandra Pouget; Catherine Dunyach-Remy; Albert Sotto; Jean-Philippe Lavigne; Virginie Molle
Journal:  Toxins (Basel)       Date:  2021-09-23       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.